Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? (Q36017145)

11 August 2017

Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? (English)

1 reference

11 August 2017

0 references

2

Julian P T Higgins

1 reference

11 August 2017

Simon G Thompson

1

1 reference

PubMed ID

15664231

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

365

1 reference

11 August 2017

341-346

1 reference

11 August 2017

9456

1 reference

Problems in the medical interpretation of overviews

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Rationale for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Determining optimal therapy--randomized trials in individual patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Can overall results of clinical trials be applied to all patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

A consumer's guide to subgroup analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Why sources of heterogeneity in meta-analysis should be investigated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Meta-analysis. Beyond the grand mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Detecting and describing heterogeneity in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Generalizing the results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

An evidence based approach to individualising treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

A random-effects regression model for meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

The relation between treatment benefit and underlying risk in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Subgroup analysis and other (mis)uses of baseline data in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

The design of prospective epidemiological studies: more subjects or better measurements?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Meta-analysis of continuous outcome data from individual patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

Completeness of reporting trial results: effect on physicians' willingness to prescribe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917790-3

7 January 2021

10.1016/S0140-6736(05)17790-3

Identifiers

DOI

1 reference

release_63jm3qx7gnd55mlrsjahlfnzky

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/63jm3qx7gnd55mlrsjahlfnzky

24 November 2022

mapped directly with Wikidata item

PubMed ID

15664231

1 reference

PubMed ID

15664231